Physiologically based pharmacokinetic model for pralmorelin hydrochloride in rats

Drug Metabolism and Disposition

Volumn 33, Issue 10, 2005, Pages 1488-1494

  Nasu, Risa ^a   Kumagai, Yoichi ^a   Kogetsu, Hirokuni ^a   Tsujimoto, Masayuki ^b   Ohtani, Hisakazu ^b,c   Sawada, Yasufumi ^b,c  

^a KAKEN PHARMACEUTICAL CO LTD   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PRALMORELIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE; BILIARY EXCRETION; BLOOD FLOW; BRAIN; CONTROLLED STUDY; DECAPITATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG TISSUE LEVEL; EXPERIMENTAL MODEL; FAT BODY; HEART; KIDNEY; LIQUID CHROMATOGRAPHY; LIVER; MALE; MUSCLE; NONHUMAN; PLASMA; PRIORITY JOURNAL; RAT; SKIN; SMALL INTESTINE; TANDEM MASS SPECTROMETRY;

ANIMALS; LIVER; MALE; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 24944483111     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.104.001040     Document Type: Article

References (16)

1. Akhteruzzaman S, Kato Y, Kouzuki H, Suzuki H, Hisaka A, Stieger B, Meier PJ, and Sugiyama Y (1999) Carrier-mediated hepatic uptake of peptidic endothelin antagonists in rats. J Pharmacol Exp Ther 290:1107-1115.
2. Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marbach P, Petcher TJ, and Pless (1982) SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 31:1133-1140.
3. Berelowitz M, Kronheim S, Pimstone B, and Shapiro B (1978) Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences and responses to oral and intravenous glucose. J Clin Investig 61:1410-1414.
4. Bowers CY (1993) GH releasing peptides-structure and kinetics. J Pediatr Endocrinol 6:21-31.
5. Cathapermal SS, Foegh ML, Rau CS, and Ramwell PW (1991) Disposition and tissue distribution of angiopeptin in the rat. Drug Metab Dispos 19:735-739.
6. Greenfield JC, Cook KJ, and O'Leary IA (1989) Disposition, metabolism and excretion of U-71038, a novel renin inhibitor peptide, in the rat. Drug Metab Dispos 17:518-525.
7. Hosseini-Yeganeh M and McLachlan AJ (2001) Tissue distribution of terbinafine in rats. J Pharm Sci 90:1817-1828.
8. Hosseini-Yeganeh M and McLachlan AJ (2002) Physiologically based pharmacokinetic model for terbinafine in rats and humans. Antimicrob Agents Chemother 46:2219-2228.
9. Kato Y, Akhteruzzaman S, Hisaka A, and Sugiyama Y (1999) Hepatobiliary transport governs overall elimination of peptidic endothelin antagonists in rats. J Pharmacol Exp Ther 288:568-574.
10. Nirei H, Hamada K, Shoubo M, Sogabe K, Notsu Y, and Ono T (1993) An endothelin ETA receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogs. Life Sci 52:1869-1874.
11. Nishida K, Mihara K, Takino T, Nakane S, Takakura Y, Hashida M, and Sezaki H (1991) Hepatic disposition characteristics of electrically charged macromolecules in rat in vivo and in the perfused liver. Pharm Res (NY) 8:437-444.
12. Nishikibe M, Tsuchida S, Okada M, Fukuroda T, Shimamoto K, Yano M, Ishikawa K, and Ikemoto F (1993) Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive model. Life Sci 52:717-724.
13. Ondetti MA and Cushman DW (1981) Inhibition of the renin-angiotensin system. A new approach to the therapy of hypertension. J Med Chem 24:355-361.
14. Sato H, Sugiyama Y, Sawada Y, Iga T, and Hanano M (1987) Physiologically based pharmacokinetics of radioiodinated human beta-endorphin in rats. An application of the capillary membrane-limited model. Drug Metab Dispos 15:540-550.
15. Yamada T, Niinuma K, Lemaire M, Terasaki T, and Sugiyama Y (1997) Carrier-mediated hepatic uptake of the cationic cyclopeptide, octreotide, in rats. Comparison between in vivo and in vitro. Drug Metab Dispos 25:536-543.
16. Yamazaki M, Suzuki H, Hanano M, Tokui T, Komai T, and Sugiyama Y (1993) Na(+)-independent multispecific anion transporter mediates active transport of pravastatin into rat liver. Am J Physiol 264:G36-G44.